🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 17 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
14/12/2022 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/01/1996 30,36 31,01 30,30 30,89 +1,77% 2,36% 5.094.957
15/01/1996 29,76 30,42 29,76 30,36 +2,41% 2,20% 4.254.461
12/01/1996 29,46 29,88 29,28 29,64 +1,02% 2,02% 5.035.011
11/01/1996 29,34 29,64 29,10 29,34 +0,41% 1,83% 5.905.270
10/01/1996 30,06 30,12 29,10 29,22 -3,54% 3,37% 6.985.339
09/01/1996 30,47 30,77 30,18 30,30 -0,59% 1,96% 6.338.514
08/01/1996 30,06 30,53 30,00 30,47 +1,39% 1,79% 1.786.840
05/01/1996 30,30 30,42 29,94 30,06 -1,18% 1,57% 3.746.600
04/01/1996 30,18 30,59 29,94 30,42 +0,59% 2,17% 7.501.794
03/01/1996 30,65 30,71 30,12 30,24 -1,36% 1,95% 6.750.797
02/01/1996 30,89 31,01 30,59 30,65 -2,10% 1,35% 6.354.234
29/12/1995 31,43 31,61 31,19 31,31 -0,76% 1,33% 3.988.478
28/12/1995 30,89 31,73 30,89 31,55 +1,93% 2,70% 5.047.378
27/12/1995 31,85 31,91 30,95 30,95 -2,63% 3,00% 3.380.638
26/12/1995 31,13 31,91 30,83 31,79 +2,50% 3,45% 3.985.125
22/12/1995 30,95 31,07 30,65 31,01 +0,00% 1,35% 3.952.427
21/12/1995 30,12 31,07 30,00 31,01 +2,97% 3,56% 7.729.629
20/12/1995 30,24 30,59 30,12 30,12 -0,79% 1,58% 6.037.738
19/12/1995 30,83 30,95 30,06 30,36 -1,93% 2,90% 7.648.723
18/12/1995 31,01 31,13 30,77 30,95 -1,33% 1,15% 4.659.408
15/12/1995 31,91 31,91 31,25 31,37 -1,68% 2,06% 11.125.778
14/12/1995 31,07 32,08 31,07 31,91 +2,69% 3,26% 7.791.251
13/12/1995 30,42 31,19 30,36 31,07 +2,96% 2,75% 7.081.546
12/12/1995 30,06 30,42 30,06 30,18 +0,00% 1,19% 3.901.914
11/12/1995 30,12 30,30 30,00 30,18 -0,39% 0,99% 3.881.163
08/12/1995 30,36 30,65 30,18 30,30 +0,20% 1,57% 3.937.336
07/12/1995 30,30 30,77 30,24 30,24 -0,59% 1,77% 5.123.253
06/12/1995 30,24 30,42 30,18 30,42 +0,59% 0,79% 5.680.160
05/12/1995 29,58 30,36 29,52 30,24 +2,22% 2,82% 6.809.066
04/12/1995 29,34 29,64 29,22 29,58 +0,61% 1,42% 4.600.510